Cargando…
Management of Marginal Zone Lymphoma: A Canadian Perspective
Marginal zone lymphomas (MZL) are a rare, heterogenous group of lymphomas, accounting for 5–17% of indolent non-Hodgkin lymphomas in the western world. They can be further divided into three subtypes: extranodal MZL, splenic MZL, and nodal MZL. These subtypes differ in clinical presentation and beha...
Autores principales: | Peters, Anthea, Keating, Mary-Margaret, Nikonova, Anna, Doucette, Sarah, Prica, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955247/ https://www.ncbi.nlm.nih.gov/pubmed/36826096 http://dx.doi.org/10.3390/curroncol30020135 |
Ejemplares similares
-
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022) -
Marginal zone lymphoma: present status and future perspectives
por: Cheah, Chan Y., et al.
Publicado: (2022) -
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021) -
Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
por: Denlinger, Nathan M, et al.
Publicado: (2018) -
Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)